tiprankstipranks
Trending News
More News >

ASKA Pharmaceutical Reports Strong Sales and Positive Outlook for FY2025

Story Highlights
ASKA Pharmaceutical Reports Strong Sales and Positive Outlook for FY2025

Confident Investing Starts Here:

ASKA Pharmaceutical Holdings Co., Ltd. ( (JP:4886) ) has provided an announcement.

ASKA Pharmaceutical Holdings Co., Ltd. reported a 2.1% year-on-year increase in net sales to 64.1 billion yen for FY2024, driven by robust performance in its pharmaceuticals and animal health businesses. Despite rising R&D expenses impacting operating profit, the company forecasts a significant 16.9% increase in net sales and a 27.5% rise in operating profit for FY2025, indicating strong future growth prospects.

More about ASKA Pharmaceutical Holdings Co., Ltd.

ASKA Pharmaceutical Holdings Co., Ltd. operates in the pharmaceutical industry, focusing on pharmaceuticals and animal health products. The company is known for its strong sales performance in these sectors, achieving record-high sales figures.

Average Trading Volume: 47,952

Technical Sentiment Signal: Strong Buy

Current Market Cap: Yen61.9B

Learn more about 4886 stock on TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1